Dr. Pedro Pérez Segura
Training, Qualifications and Honours
- Degree in Medicine and Surgery from Universidad Complutense of Madrid (1992)
- D in Medicine and Surgery from Universidad Complutense of Madrid (1997)
- Medical Oncology Specialist, via MIR Internship, Hospital Universitario Clínico San Carlos (1994-1998)
- Master’s Degree in “Senior Management of Health and Business Management Services” Agencia Laín Entralgo and Universidad de Alcalá de Henares Health Council of the Autonomous Community of Madrid
- Founding Member of the Hereditary Cancer Section of the Spanish Society of Medical Oncology
- Coordinator of the Prevention Area of the Spanish Society of Medical Oncology
- Professor at the School of Medicine at Universidad Complutense of Madrid
Professional Career
- 1999 – Present, Associate of the Medical Oncology Service of Hospital Universitario Clínico San Carlos of Madrid, responsible for the Neuro-Oncology, Head and Neck Cancer and Family Cancer Units
- 2007 – Present, Head of Quality of the Oncological management Unit of Hospital Clínico San Carlos of Madrid
- 1992 – 1993, Primary Care Physician (INSALUD), Madrid
Teaching
- Associate Professor of the Faculty of Medicine of Universidad Complutense of Madrid and Master’s Degree in Health Management and Direction Services from Universidad de Alcalá de Henares
- Participation in various healthcare committees at Hospital Clínico San Carlos de Madrid
Publications, Conferences and Papers
- AEBM-Reference Prize in 2005 awarded for the paper presented at the 14th National Clinical Laboratory Conference on “Prevalence of germinal mutations in hMLH1, hMSH2 and hMSH6 in Spanish families with non-polyposic colon cancer” Alicante, June 2005
- Prize for the best oncology film of the 3rd “Videoprimaria” International Medical Video Competition in 2005 called “Prevention of breast cancer in patients with BRCA1 mutation” Vigo, November 2005
- 2nd Prize for “Support for Oncology Research”, promoted by Novartis, with the project titled “Detection of mutations in susceptibility genes in hereditary breast cancer, BRCA1 and 2, in Spanish families, and their clinical y pathological correlation”, November 2000.
- Collaboration in multiple articles in national and international books and journals in the field of medical oncology and, more specifically, in genetic counselling.
Affiliations
- Expert at the EMEA for assessment of new oncological drugs (since 2006)
- Expert at the Directorate General of Advanced Therapies and Transplants (DGTATX) of the Ministry of Health and Social Policy for assessment of research projects
- Expert at the Spanish Medicines Agency for the assessment of new oncological drugs (since 2006)
- Coordinator of the Alliance for the Prevention of Colon Cancer (from 2014 to 2016)
- Chairman of the technical committee of the Spanish Cancer Association- AECC (Provincial Board of Madrid)
- Chairman of the Spanish Neuro-oncology Research Group (GEINO) from 2014 to 2016
- Member of the Spanish Medical Oncology Society (SEOM)
- Coordinator and Founding Member of the Hereditary Cancer Section of the Spanish Society of Medical Oncology (SEOM) (since 2001)
- Member of the American Society of Clinical Oncology (ASCO)
- Member of the ICG-HNPCC
- Member of the Spanish Digestive Tumor Treatment Group (TTD)
- Member of the Scientific Committee of the “Alliance for the Prevention of Colorectal Cancer”
- Member of the AEGH (Spanish Association of Human Genetics)
R&D Projects
- Participation in more than 200 clinical trials in different areas of oncology
- Participation in trials which have allowed the approval of antineoplastic therapies by international and national regulatory agencies
- Development of trial phases I, II, III and IV; gene therapy and chemoprevention
